BiotechTube

EVT 201

Phase 2Completed
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Sleep Initiation and Maintenance Disorders

Conditions

Sleep Initiation and Maintenance Disorders

Trial Timeline

Sep 1, 2006 → Apr 1, 2007

NCT ID
NCT00380003

About EVT 201

EVT 201 is a phase 2 stage product being developed by Evotec for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00380003. Target conditions include Sleep Initiation and Maintenance Disorders.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00401284Phase 2Completed
NCT00380003Phase 2Completed

Competing Products

20 competing products in Sleep Initiation and Maintenance Disorders

See all competitors
ProductCompanyStageHype Score
Daridorexant + PlaceboIdorsiaPhase 1
28
LY2422347 + placeboEli LillyPhase 2
52
LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - CapsuleEli LillyPhase 1
33
Zolpidem MR + EstazolamAstellas PharmaApproved
85
zolpidem MR + nitrazepam + placeboAstellas PharmaPhase 3
77
FK199B + ZolpidemAstellas PharmaPhase 3
77
Zolpidem MR + Zolpidem IRAstellas PharmaApproved
85
Zolpidem MR + ZolpidemAstellas PharmaPhase 3
77
Sivopixant + Placebo + Acetazolamide + SASS-001ShionogiPhase 2
52
Placebo + Lemborexant 10 mg + Lemborexant 25 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
Lemborexant + PlaceboEisaiApproved
85
Zonisamide + PlaceboEisaiPhase 2
52
Lemborexant 2.5 mg + Lemborexant 5 mg + Lemborexant 10 mg + Lemborexant 15 mg + Lemborexant-matched placeboEisaiPhase 2
52
Placebo + Lemborexant 10 mg + Placebo + Lemborexant 10 mgEisaiPhase 1
33
LemborexantEisaiPhase 2
52
Lemborexant + PlaceboEisaiPhase 3
77
LemborexantEisaiPre-clinical
23
Istradefylline (KW-6002)Kyowa KirinPhase 2
52
Eloralintide + PlaceboEli LillyPhase 3
77
Tirzepatide + PlaceboEli LillyPhase 3
77

Other Products from Evotec

EVT 302, 10 mg + placebo + Nicotine replacement therapy (NRT)Phase 2
47
EVT 201Phase 2
47
EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine ReplacementPhase 2
47
EVT 101 + EVT 101 + placeboPhase 1
28
Monoclonal antibody JST-010 + PlaceboPhase 1
28